DK126000B - Analogifremgangsmåde til fremstilling af en terapeutisk virksom forbindelse eller syreadditionssalte eller kvaternære ammoniumsalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af en terapeutisk virksom forbindelse eller syreadditionssalte eller kvaternære ammoniumsalte deraf.Info
- Publication number
- DK126000B DK126000B DK116471AA DK116471A DK126000B DK 126000 B DK126000 B DK 126000B DK 116471A A DK116471A A DK 116471AA DK 116471 A DK116471 A DK 116471A DK 126000 B DK126000 B DK 126000B
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- quaternary ammonium
- active compound
- acid addition
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR707008932A FR2081572B1 (pl) | 1970-03-12 | 1970-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK126000B true DK126000B (da) | 1973-05-28 |
Family
ID=9052168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK116471AA DK126000B (da) | 1970-03-12 | 1971-03-11 | Analogifremgangsmåde til fremstilling af en terapeutisk virksom forbindelse eller syreadditionssalte eller kvaternære ammoniumsalte deraf. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3759924A (pl) |
| JP (1) | JPS5341156B1 (pl) |
| AT (1) | AT303042B (pl) |
| BE (1) | BE764133A (pl) |
| CA (1) | CA933928A (pl) |
| CH (1) | CH521347A (pl) |
| DE (1) | DE2112026C3 (pl) |
| DK (1) | DK126000B (pl) |
| ES (1) | ES389180A1 (pl) |
| FI (1) | FI49034C (pl) |
| FR (1) | FR2081572B1 (pl) |
| GB (1) | GB1285016A (pl) |
| IE (1) | IE35209B1 (pl) |
| IL (1) | IL36398A (pl) |
| NL (1) | NL7102897A (pl) |
| NO (1) | NO133400C (pl) |
| SE (1) | SE360655B (pl) |
| ZA (1) | ZA711602B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61109470U (pl) * | 1984-12-20 | 1986-07-11 | ||
| US20020028813A1 (en) * | 1997-09-03 | 2002-03-07 | Paul F. Jackson | Thioalkyl compounds, methods, and compositions for inhibiting parp activity |
| US6426415B1 (en) | 1997-09-03 | 2002-07-30 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity |
| US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| WO1999011622A1 (en) * | 1997-09-03 | 1999-03-11 | Guilford Pharmaceuticals Inc. | Amino-substituted compounds, methods, and compositions for inhibiting parp activity |
| US6291425B1 (en) | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| US6346536B1 (en) | 1997-09-03 | 2002-02-12 | Guilford Pharmaceuticals Inc. | Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same |
| US6197785B1 (en) | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
| US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| US6395749B1 (en) | 1998-05-15 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| US6387902B1 (en) | 1998-12-31 | 2002-05-14 | Guilford Pharmaceuticals, Inc. | Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP |
| AU2001264595A1 (en) | 2000-05-19 | 2001-12-03 | Guilford Pharmaceuticals Inc. | Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses |
| WO2001091796A2 (en) | 2000-06-01 | 2001-12-06 | Guilford Pharmaceuticals Inc. | Methods, compounds and compositions for treating gout |
| US6545011B2 (en) | 2000-07-13 | 2003-04-08 | Guilford Pharmaceuticals Inc. | Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses |
| MX2010012848A (es) | 2008-06-03 | 2011-03-01 | Intermune Inc | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. |
| AR092742A1 (es) * | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3227085A (en) * | 1963-09-05 | 1966-01-04 | James L Ramer | Shot shell |
| DE1670694B2 (de) * | 1966-05-05 | 1976-07-22 | Hoechst Ag, 6000 Frankfurt | Verfahren zur herstellung von tetrahydroisochinolinen |
| FR2028672A6 (pl) * | 1968-03-06 | 1970-10-16 | Rhone Poulenc Sa | |
| FR1583755A (pl) * | 1968-03-06 | 1969-12-05 | ||
| GB1244501A (en) * | 1968-03-09 | 1971-09-02 | Aspro Nicholas Ltd | Heterocyclic amines |
-
1970
- 1970-03-12 FR FR707008932A patent/FR2081572B1/fr not_active Expired
-
1971
- 1971-02-12 FI FI710404A patent/FI49034C/fi active
- 1971-03-04 NL NL7102897A patent/NL7102897A/xx not_active Application Discontinuation
- 1971-03-11 JP JP1285971A patent/JPS5341156B1/ja active Pending
- 1971-03-11 US US00123375A patent/US3759924A/en not_active Expired - Lifetime
- 1971-03-11 CH CH359771A patent/CH521347A/fr not_active IP Right Cessation
- 1971-03-11 DK DK116471AA patent/DK126000B/da unknown
- 1971-03-11 NO NO925/71A patent/NO133400C/no unknown
- 1971-03-11 BE BE764133A patent/BE764133A/xx unknown
- 1971-03-11 IL IL36398A patent/IL36398A/en unknown
- 1971-03-11 ZA ZA711602A patent/ZA711602B/xx unknown
- 1971-03-11 IE IE307/71A patent/IE35209B1/xx unknown
- 1971-03-11 CA CA107530A patent/CA933928A/en not_active Expired
- 1971-03-11 SE SE03148/71A patent/SE360655B/xx unknown
- 1971-03-12 AT AT216171A patent/AT303042B/de not_active IP Right Cessation
- 1971-03-12 ES ES389180A patent/ES389180A1/es not_active Expired
- 1971-03-12 DE DE2112026A patent/DE2112026C3/de not_active Expired
- 1971-04-19 GB GB23784/71A patent/GB1285016A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1285016A (en) | 1972-08-09 |
| CH521347A (fr) | 1972-04-15 |
| DE2112026A1 (de) | 1971-09-23 |
| IE35209B1 (en) | 1975-12-10 |
| JPS5341156B1 (pl) | 1978-10-31 |
| NO133400C (pl) | 1976-04-28 |
| NL7102897A (pl) | 1971-09-14 |
| FR2081572B1 (pl) | 1973-04-06 |
| CA933928A (en) | 1973-09-18 |
| IL36398A (en) | 1973-10-25 |
| FR2081572A1 (pl) | 1971-12-10 |
| FI49034B (pl) | 1974-12-02 |
| IE35209L (en) | 1971-09-12 |
| ZA711602B (en) | 1971-11-24 |
| IL36398A0 (en) | 1971-05-26 |
| DE2112026C3 (de) | 1979-10-25 |
| US3759924A (en) | 1973-09-18 |
| ES389180A1 (es) | 1973-06-01 |
| AT303042B (de) | 1972-11-10 |
| DE2112026B2 (de) | 1979-03-08 |
| BE764133A (fr) | 1971-09-13 |
| SE360655B (pl) | 1973-10-01 |
| FI49034C (fi) | 1975-03-10 |
| NO133400B (pl) | 1976-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK115847B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2,4-diamino-5-benzyl-pyrimidinderivater eller syreadditionssalte deraf. | |
| DK129446B (da) | Analogifremgangsmåde til fremstilling af fenoxyhydroxypropylaminer eller syreadditionssalte heraf. | |
| DK126000B (da) | Analogifremgangsmåde til fremstilling af en terapeutisk virksom forbindelse eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK131858B (da) | Analogifremgangsmåde til fremstilling af 4-amino-6-arylpyrimidin-forbindelser eller syreadditionssalte deraf. | |
| DK133372B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf. | |
| DK134222B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme aminer eller syreadditionssalte deraf. | |
| DK120341B (da) | Analogifremgangsmåde til fremstilling af benzoxacinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf. | |
| DK122133B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK114200B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme, basisk substituerede cycloalkenderivater eller syreadditionssalte deraf. | |
| DK127599B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf. | |
| DK131148B (da) | Analogifremgangsmåde til fremstilling af derivater af phenanthridin eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK139582B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf. | |
| DK109141C (da) | Fremgangsmåde til fremstilling af substituerede 2-hydroxy-hexahydro-11bH-benzo[a]quinoliziner, estere deraf eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf. | |
| DK131030B (da) | Fremgangsmåde til fremstilling af N-diethylaminoethyl-2-methoxy-4-amino-5-chlorbenzamid eller syreadditionssalte eller kvaternære ammoniumsalte heraf. | |
| DK128494C (da) | Fremgangsmåde til fremstilling af amidino-urinstoffer eller syreadditionssalte heraf. | |
| DK129164B (da) | Analogifremgangsmåde til fremstilling af 3-alkyl-5-aryloxymethylisoxazoler eller syreadditionssalte deraf. | |
| DK130114B (da) | Analogifremgangsmåde til fremstilling af 5,6-dihydrofenantridinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK115842B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. | |
| DK118613B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 3,4-dihydroxyphenyl-alkanolaminer eller syreadditionssalte heraf. | |
| DK124944B (da) | Analogifremgangsmåde til fremstilling af substituerede 2-arylalkyloxybenzamider eller syreadditionssalte eller kvaternære ammoniumsalter deraf. | |
| DK133503B (da) | Fremgangsmåde til fremstilling af 4-chlor-5-sulfamoyl-anthranilsyrederivater eller metal- eller ammoniumssalte deraf. | |
| DK130288B (da) | Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. | |
| DK129718B (da) | Analogifremgangsmåde til fremstilling af tiazolino-pyrimidin-5-oner eller deres syreadditionssalte eller de tilsvarende optisk aktive forbindelser. | |
| DK114624B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive, substituerede quinoliziner eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK103669C (da) | Fremgangsmåde til fremstilling af phenthiazinderivater eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf. |